KO

Business Context and Reporting Period

Company: The Coca-Cola Company (KO)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended September 27, 2024
Business Overview: The Company manufactures, markets, and sells non-alcoholic beverage concentrates and syrups. The reporting period reflects continued structural changes, including the refranchising of bottling operations in the Philippines, Bangladesh, and certain territories in India, which significantly impacted segment reporting and operating income.

Key Financial Metrics

Margins (9M 2024 vs 9M 2023):
- Gross Profit Margin: 61.4% (up from 60.2%)
- Operating Margin: 20.5% (down from 25.9%)

Material Changes vs. Prior Period

• Revenue: Q3 2024 revenues decreased 1% year-over-year, primarily due to unfavorable foreign currency fluctuations (-5%) and acquisitions/divestitures (-4%), partially offset by favorable price, product, and geographic mix (+10%). For the nine months, revenue increased 2%.
• Operating Income: Q3 operating income declined 23% to $2.51 billion. The decrease was driven by higher other operating charges, unfavorable foreign currency impacts (-15%), and the impact of refranchising bottling operations. Nine-month operating income decreased 19%.
• Other Operating Charges: Charges increased significantly to $1.044 billion in Q3 (vs. $359 million in Q3 2023) and $3.987 billion for the nine months (vs. $1.808 billion). Key drivers included:
  • $919 million (Q3) / $3.021 billion (9M) related to the remeasurement of contingent consideration for the fairlife acquisition.
  • $760 million (9M) impairment charge related to the BodyArmor trademark.
  • $87 million (Q3 & 9M) impairment of a trademark in Latin America.
• Other Income (Loss): Q3 2024 included a net gain of $491 million, driven by a $338 million gain on the sale of a portion of the interest in Coca-Cola Consolidated and $103 million in investment gains. Nine-month other income was $2.006 billion, boosted by gains from refranchising bottling operations in the Philippines ($595 million) and India ($290 million), and the sale of a Thailand equity interest ($506 million).
• Cash Flow: Operating cash flow for the nine months dropped 68% to $2.854 billion, primarily due to a $6.0 billion tax litigation deposit paid to the IRS.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management expects foreign currency exchange rate fluctuations to have an unfavorable impact on full-year 2024 net operating revenues and operating income. The Company expects 2024 capital expenditures to be approximately $2.2 billion.
• Tax Litigation (Critical Risk): The Company is in ongoing litigation with the IRS regarding transfer pricing for tax years 2007–2009. The Tax Court ruled against the Company, resulting in a $6.0 billion liability (including interest) which the Company paid in September 2024 to stop interest accrual. The Company has appealed the decision.
  • Contingency: If the Company does not prevail, it may not receive a refund of the $6.0 billion paid. Additionally, the Company estimates a potential aggregate remaining incremental tax and interest liability of approximately $10 billion for tax years 2010–2023 if the Tax Court methodology is applied to subsequent years.
• Impairments: A $760 million impairment of the BodyArmor trademark was recorded in Q1 2024 due to revised operating projections and higher discount rates. Management noted that if near-term results do not meet projections, additional impairment charges may be required.
• Dividends: The Board approved a quarterly dividend of $0.485 per share, payable December 16, 2024.

Key Facts for Investor Verification

• Tax Litigation Exposure: Verify the status of the appeal to the U.S. Court of Appeals for the Eleventh Circuit regarding the $6.0 billion IRS payment and the potential $10 billion exposure for subsequent years.
• BodyArmor Performance: Monitor future operating results of the BodyArmor brand to assess the risk of further impairment charges following the $760 million write-down.
• Structural Changes Impact: Confirm the long-term financial impact of the refranchising of bottling operations in the Philippines, Bangladesh, and India on the "Bottling Investments" segment and consolidated revenue recognition.
• Cash Flow Volatility: Note that the significant drop in operating cash flow was largely due to the one-time tax deposit; verify if this distorts the assessment of core operational cash generation.
• Foreign Currency Hedging: Review the effectiveness of hedging strategies given the stated expectation of unfavorable currency impacts on full-year results.